Allergy

Article	Citations
In this Issue: Graphical Abstracts	665
Clinical applicability of the urticaria control test in patients with chronic urticaria: Further evidence from 622 adult and pediatric patients with different disease subtypes	330
Legends of allergology and immunology: Per Brandtzaeg – Pillar of mucosal immunology	279
Correspondence to “Basophil activation test as predictor of severity and threshold of allergic reactions to egg”	245
Pre‐existing inflammation reduces the response to contact allergens in Tmem79‐deficient mice	185
Issue Information	174
Large scale regulatory T cells screening	163
Correspondence to “Allergic bronchopulmonary aspergillosis with atopic, nonatopic, and sans asthma—Factor analysis”	149
In memoriam: Lawrence M. Lichtenstein (1934–2022)	143
Issue Information	140
Issue Information	137
25‐hydroxyvitamin D and risk of atopic diseases and infections in early childhood	121
In Memory of Dr. Izabela Kuprys‐Lipinska: A Pioneering Clinician, Scientist, and Beloved Friend	116
Low‐affinity but high‐avidity interactions may offer an explanation for IgE‐mediated allergen cross‐reactivity	114
Next generation health guidelines: The role of real‐life data in evidence‐based medicine	112
Intranasal administration of a virus like particles‐based vaccine induces neutralizing antibodies against SARS‐CoV‐2 and variants of concern	105
An algorithm for the diagnosis and management of IgE‐mediated food allergy, 2024 update	104
One‐strength dose escalation of house dust mite depot product for subcutaneous immunotherapy is safe and tolerable	104
Impact of COVID‐19 on care‐seeking patterns for hay fever in Japan: A retrospective claims database cohort study	98
The Role of IgE in Crohn's Disease by Impairing the Capacity of Plasmacytoid Dendritic Cells to Generate FOXP3+ Tregs	96
Type 2 memory B cells: The repository of allergic memory?	95
Medical algorithm: Peri‐operative management of mastocytosis patients	91
Algorithms in allergy: An algorithm for alpha‐Gal syndrome diagnosis and treatment, 2024 update	91
Shotgun metagenomic sequencing on skin microbiome indicates dysbiosis exists prior to the onset of atopic dermatitis	91
In vivo and ex vivo inflammatory responses of the esophageal mucosa to food challenge in adults with eosinophilic esophagitis	87

Health effects of exposure to chlorination by‐products in swimming pools	82
Oral and Gut Microbial Hubs Associated With Reaction Threshold Interact With Circulating Immune Factors in Peanut Allergy	81
Efficacy and safety of intranasal medications for allergic rhinitis: Network meta‐analysis	80
The impact of exposure to tobacco smoke and e‐cigarettes on asthma‐related outcomes: Systematic review informing the EAACI guidelines on environmental science for allergic diseases and asthma	80
Longitudinal analyses of development of the immune system during the first five years of life in relation to lifestyle	80
The Presence and Pathogenic Roles of M(IL‐33 + IL‐2) Macrophages in Allergic Airway Inflammation	78
TOP10‐SCAR: A Global Pharmacovigilance Study on Medications Most Frequently Related to Severe Cutaneous Adverse Reactions	77
Prevention of infant eczema by neonatal Bacillus Calmette‐Guérin vaccination: The MIS BAIR randomized controlled trial	76
Airway epithelial cell cilia transcriptomic dysregulation is associated with the inflammatory phenotype in asthma	75
The second COVID‐19 mRNA vaccine dose enhances the capacity of Spike‐specific memory B cells to bind Omicron BA.2	71
MUC1 deficiency induces the nasal epithelial barrier dysfunction via RBFOX3 shortage augment ubiquitin–proteasomal degradation in allergic rhinitis pathogenesis	70
Persistence of infectious SARS‐CoV‐2 particles for up to 37 days in patients with mild COVID‐19	70
Immunoglobulin E response in health and disease beyond allergic disorders	70
Dupilumab improves health related quality of life: Results from the phase 3 SINUS studies	69
	69
Development and validation of the food allergy severity score	66
Autoantibodies in COVID‐19 correlate with antiviral humoral responses and distinct immune signatures	66
Medical algorithm: Diagnosis and treatment of hypersensitivity reactions to cancer chemotherapy	65
Prospective (e‐diary) vs retrospective (ARIA) measures of severity in allergic rhinoconjunctivitis: An observational compatibility study	64
Vaccine based on folded receptor binding domain‐PreS fusion protein with potential to induce sterilizing immunity to SARS‐CoV‐2 variants	62
Long‐term safety and efficacy of garadacimab for preventing hereditary angioedema attacks: Phase 3 open‐label extension study	61
Allergenic components of the mRNA‐1273 vaccine for COVID‐19: Possible involvement of polyethylene glycol and IgG‐mediated complement activation	61
Angiomotin and angiostatin as asthma biomarkers: Implications for the regulation of airway remodeling and inflammation	61
Hot topics in allergen immunotherapy, 2023: Current status and future perspective	59
Impact of climate change on atopic dermatitis: A review by the International Eczema Council	59
Experimental rhinovirus infection induces an antiviral response in circulating B cells which is dysregulated in patients with asthma	59
Core Outcome Set for IgE‐mediated food allergy clinical trials and observational studies of interventions: International Delphi consensus study ‘COMFA’	58
Detection of SARS‐CoV‐2‐specific memory B cells to delineate long‐term COVID‐19 immunity	58
Discrepancies in Beta‐Lactam Antibiotics Cross‐Reactivity: Implications for Clinical Practice	58
Issue Information ‐ TOC	57
The Molecular Allergology User's Guide version 2.0 is freely available!	56
In this Issue: Graphical Abstracts	56
Reply to “Aspergillus fumigatus and personalized medicine: Toward a clinically reliable algorithm”	56
Issue Information	56
Evidence of epithelial remodelling but not epithelial–mesenchymal transition by transcriptome profiling in vernal keratoconjunctivitis	55
Issue Information	55
Neuron−macrophage interaction in the healing process of the skin	54
Immunotherapeutic effects of specific and nonspecific mRNA‐lipid nanoparticles in a mouse model of HDM‐induced airway inflammation	54
Allergoid‐mannan conjugates imprint tolerogenic features in human macrophages	53
What we know and still ignore on COVID‐19 immune pathogenesis and a proposal based on the experience of allergic disorders	53
Sputum transcriptome analysis of co‐regulated genes related to arachidonic acid metabolism in N‐ERD	53
Acute scrotum in a 8‐year‐old Italian child caused by extraintestinal anisakiasis in a seaside area	52
The epithelial barrier hypothesis: a 20‐year journey	52
Molecular sensitization patterns in animal allergy: Relationship with clinical relevance and pet ownership	52
EAACI guidelines on environmental science in allergic diseases and asthma – Leveraging artificial intelligence and machine learning to develop a causality model in exposomics	52
CytoBas: Precision component‐resolved diagnostics for allergy using flow cytometric staining of basophils with recombinant allergen tetramers	52
TFEB signaling attenuates NLRP3‐driven inflammatory responses in severe asthma	52
Differential presentation of hypersensitivity reactions to carboplatin and oxaliplatin: Phenotypes, endotypes, and management with desensitization	51
Benralizumab restores gene and microRNA expression involved in steroid sensitivity in severe asthma	50
Heterogeneity of pollen food allergy syndrome in seven Southern European countries: The @IT.2020 multicenter study	50

Effects of allergen immunotherapy in the MASK‐air study: a proof‐of‐concept analysis	49
Network analysis reveals age‐ and virus‐specific circuits in nasal epithelial cells of extremely premature infants	49
Single inhaler triple therapy (SITT) in asthma: Systematic review and practice implications	49
NK cells and lipoxin A4 promote resolution of eosinophilic inflammation after nasal allergen challenge	49
Epigenetic regulation of epithelial dectin‐1 through an IL‐33‐STAT3 axis in allergic disease	49
	48
Severe and refractory anaphylaxis in pediatric intensive care unit	48
Type 2 IgG Memory B Cells as Precursors of IgE Plasma Cells	47
Tissue‐specific contribution of mucosal‐associated invariant T cells to allergic airway inflammation	47
Nutritional and environmental exposures in athletes: Implications on the epithelial barrier function	46
Oral abstracts (OAS)	45
Management of anaphylaxis due to COVID‐19 vaccines in the elderly	44
Reply to correspondence: “The effectiveness of pollen allergen immunotherapy on allergic rhinitis over 18 years: A national cohort study in Denmark”	44
Recurrence of anaphylaxis: A systematic review of observational studies	44
CT‐P39 Compared With Reference Omalizumab in Chronic Spontaneous Urticaria: Results From a Double‐Blind, Randomized, Active‐Controlled, Phase 3 Study	44
Non‐immediate hypersensitivity reactions to iomeprol: Diagnostic value of skin tests and cross‐reactivity with other iodinated contrast media	44
Childhood infections, asthma and allergy trajectories, and chronic rhinosinusitis in middle age: A prospective cohort study across six decades	44
Allergic Reactivity and Memory Occur Independently of Sequential Switching Through IgG1	43
Early expansion of allergen‐responsive LAP+ B regulatory cells in allergic rhinitis but not in allergic asthma subjects during allergen immunotherapy	43
Issue Information	43
Beta2‐adrenergic agonists can enhance intense performance and muscle strength in healthy individuals	42
Allergic airway inflammation delays glioblastoma progression and reinvigorates systemic and local immunity in mice	42
Anatomical Distribution and Quantification of IgE Secretion in Mouse Models of House Dust Mite Allergy	42
COVID‐19 vaccines tolerated in patients with paclitaxel and docetaxel allergy	41
Natural course of pollen‐induced allergic rhinitis from childhood to adulthood: A 20‐year follow up	41
Efficacy and safety of topical Streptococcus postbiotic emollient in adolescents and adults with mild‐to‐moderate atopic dermatitis: A randomized, double‐blind, vehicle‐controlled trial	41
Mast cell activation is associated with post‐acute COVID‐19 syndrome	41
Development of the Cold Urticaria Activity Score	41
Successful rapid desensitization in a glioma patient with procarbazine‐mediated anaphylaxis	41
Cashew oral immunotherapy for desensitizing cashew‐pistachio allergy (NUT CRACKER study)	40
Issue Information	40
Targeting interleukin‐5 with benralizumab: A novel treatment for drug rash with eosinophilia and systemic symptoms	40
Biological treatment in allergic disease	40
IL‐13: An essential cDC2s partner to maintain skin homeostasis	40
Sweet syndrome induced by SARS‐CoV‐2 Pfizer‐BioNTech mRNA vaccine	40
Issue Information	40
In this issue: Graphical abstract	40
Glatiramer acetate induces mast cell degranulation via MRGPRX2, implications for local and systemic adverse reactions	39
Indirect case‐matched comparison of anti‐IL4Rα versus anti‐IL5Rα on airway hyperresponsiveness	39
Oncostatin‐M Is Produced by Human Eosinophils and Expression Is Increased in Uncontrolled Severe Asthma	39
Prevalence of hypersensitivity reactions in various forms of mastocytosis: A pilot study of 2485 adult patients with mastocytosis collected in the ECNM registry	38
A vaccine targeting human IL‐4 and IL‐13 protects against asthma in humanized mice	38
Cost‐effectiveness analysis of house dust mite allergen immunotherapy in children with allergic asthma	38
Serological testing for SARS‐CoV‐2 antibodies in clinical practice: A comparative diagnostic accuracy study	38
Optimal dose of adrenaline auto‐injector for children and young people at risk of anaphylaxis: A phase IV randomized controlled crossover study	37
Exiting the Anthropocene: Achieving personal and planetary health in the 21st century	37
ACE2 downregulation in olfactory mucosa: Eosinophilic rhinosinusitis as COVID‐19 protective factor?	36
Legends of allergy and immunology: Otto Scheiner	36
Genetic variants in the TLR‐related pathway and smoking exposure alter the upper airway microbiota in adult asthmatic patients	36
Quantitative analysis of urinary cytokines in food‐allergic and healthy individuals	35
IL‐13 signature in severe adult asthmatics with airway neutrophilia: A new endotype to treat!	35
Effect of venom immunotherapy and sting challenge on health‐related quality of life measured by venom‐allergy quality of life questionnaire (VQLQ) in Jack jumper ant allergic patients	34
Patient‐reported outcome measures in birch pollen allergic patients treated with sublingual immunotherapy reflect real life	34
Intralymphatic Administration of Naked mRNA Induces Allergen‐Specific IgG, Promotes Th1 Responses and Reduces Anaphylactic Potential	34
Allergen‐Specific B Cell Responses Following Desensitisation and Natural Tolerance to Cow's Milk Allergy	33
Issue Information	33
SEB‐induced IL‐13 production in CLA+ memory T cells defines Th2 high and Th2 low responders in atopic dermatitis	33
Food Allergy Genetics and Epigenetics: A Review of Genome‐Wide Association Studies	33
Combining avidin with CD63 improves basophil activation test accuracy in classifying peanut allergy	33
Salivary Metabolomic Signatures in Pediatric Eosinophilic Esophagitis	33
Harnessing mass spectrometric methods for exquisite allergen product characterization	33
Abstract	32
Emollients for prevention of atopic dermatitis: 5‐year findings from the BEEP randomized trial	32
Efficacy and Safety Profile of Animal Dander Immunotherapy: A Multicentre UK Study	32
Impact of a drug allergy education course for non‐specialists: Findings from ADAPT—A randomized crossover trial	32
SARS‐CoV‐2 infection in severe asthma is associated with worsening of COVID‐19 through respiratory NLRP3 inflammasome activation	32
Sex hormones and asthma: The role of estrogen in asthma development and severity	31
Incidence of healthcare utilization for allergic and respiratory infectious diseases in children with asthma before and during the COVID‐19 pandemic	31
Can polyamine metabolism in T helper cell lineage commitment be a new target in allergy research?	31
Bovine γ‐globulin, lactoferrin, and lactoperoxidase are relevant bovine milk allergens in patients with α‐Gal syndrome	31
	31
An injectable excipient prevents anti‐polyethylene glycol antibody‐mediated hypersensitivity	31
Mapping the way to strengthening epithelial barriers: Neuronal circuits in mucus regulation	31
Gene therapy for a murine model of eosinophilic esophagitis	30
Is there a direct link between skin barrier dysfunction and asthma?	30
Safety of COVID‐19 vaccine challenge in patients with immediate adverse reactions to prior doses: A multi‐centre cohort study	30
The impact of dupilumab treatment on SARS‐CoV‐2 T cell responses in atopic dermatitis patients	30
Issue Information	30
Thrombin cleaves IL‐33 and modulates IL‐33‐activated allergic lung inflammation	30
Issue Information	30

Author Index	30
Legends of Allergy and Immunology: Gianni Marone	30
Effects of the immunoglobulin/histamine complex in chronic spontaneous urticaria focusing on remission induction	30
Efficacy of eHealth monitoring in pediatric asthma	29
IgE‐cross‐blocking antibodies to Fagales following sublingual immunotherapy with recombinant Bet v 1	29
The Bronchodilator and Anti‐Inflammatory Effect of Long‐Acting Muscarinic Antagonists in Asthma: An EAACI Position Paper	29
Interferon‐γ‐inducible protein 10 augments atopic dermatitis via amplifying Th2 immune response	29
Gut microbiota and Lactobacillus species maintain the small intestine stem cell niche and ameliorate the severity of necrotizing enterocolitis	29
	29
The stimulation of TH2 cells results in increased IL‐5 and IL‐13 production via the H4 receptor	29
Predicting dupilumab treatment outcome in patients with primary diffuse type 2 chronic rhinosinusitis	29
Long‐term follow‐up of neutrophil activation after severe‐to‐critical SARS‐CoV‐2 infection: A longitudinal study	28
Different mechanisms distinguishing childhood allergic diseases including allergic march	28
Particulate Matter 2.5 Aggravates Airway Inflammation by Neutrophil‐Mediated Inflammasome Activation	28
Fecal microbiota transplantation against moderate‐to‐severe atopic dermatitis: A randomized, double‐blind controlled explorer trial	28
Characteristics of tissue–resident ILCs and their potential as therapeutic targets in mucosal and skin inflammatory diseases	28
Epidemiological variations in global burden of atopic dermatitis: An analysis of trends from 1990 to 2019	28
Recombinant Hypoallergenic Cat Allergy Vaccines	28
Dupilumab reduces symptom burden in allergic rhinitis and suppresses allergen‐specific IgE production	27
Type 1/17 CD103+CD4+ nasal‐resident memory T cells in non‐eosinophilic chronic rhinosinusitis with nasal polyps	27
Advances and highlights in asthma in 2021	27
Flow‐based basophil activation test in immediate drug hypersensitivity. An EAACI task force position paper	27
Allergen‐specific B cell responses in oral immunotherapy‐induced desensitization, remission, and natural outgrowth in cow's milk allergy	27
Climate change: A call to action for the United Nations	27
Differentiation of bronchial epithelial spheroids in the presence of IL‐13 recapitulates characteristic features of asthmatic airway epithelia	27
Suppressed IgG4 class switching in dupilumab‐ and TNF inhibitor‐treated patients after mRNA vaccination	27
Poultry exposure and environmental protection against asthma in rural children	26
IL‐13, periostin and dipeptidyl‐peptidase‐4 reveal endotype‐phenotype associations in atopic dermatitis	26
CLA+ memory T cells in atopic dermatitis	26
IgE glycosylation is essential for the function of omalizumab	26
Oral immunotherapy in alpha‐gal red meat allergy: Could specific IgE be a potential biomarker in monitoring management?	26
In this issue: Graphical abstract	25
Tralokinumab therapy for moderate‐to‐severe atopic dermatitis: Clinical outcomes with targeted IL‐13 inhibition	25
Issue Information	25
Potential cancer risk with omalizumab? A disproportionality analysis of the WHO's VigiBase pharmacovigilance database	25
Dietary fiber and fermented food consumption and its link to allergic responses	25
Inverse association between Helicobacter pylori infection and atopic, skin, and autoimmune diseases: A nationwide population‐based study in South Korea	25
Medical algorithm: Aspergillus fumigatus components in the diagnosis of allergic bronchopulmonary aspergillosis	25
Author Index	25
Effect‐modifying impact of age on sex‐based differences during oral immunotherapy	25
Different inflammatory features of asthma according to gut microbiome enterotype	25
Effect of indoor air pollution on atopic dermatitis in dogs	24
Infantile colic is associated with development of later constipation and atopic disorders	24
Tissue levels of Alternaria allergen Alt a 1 reflect recurrence of refractory airway diseases	24
Obituary: Professor Marcus Maurer, Berlin, Germany	24
Issue Information	24
Overcoming bacteriophage insensitivity in Staphylococcus aureus using clindamycin and azithromycinat subinhibitory concentrations	24
Reply to correspondence: Emollients in infancy to prevent atopic dermatitis: A systematic review and meta‐analysis	24
How type‐2 dendritic cells induce Th2 differentiation: Instruction, repression, or fostering T cell‐T cell communication?	24
Sesame eliciting and safe doses in a large sesame allergic population	24
COVID‐19 pandemic and allergen immunotherapy—an EAACI survey	24
Correction to “Alveolar macrophages are sentinels of murine pulmonary homeostasis following inhaled antigen challenge”	24
In this Issue: Graphical Abstracts	24
An algorithm for the management of radiocontrast media hypersensitivity, 2024 update	23
Human Milk Microbiome Is Associated With Allergic Diseases in Early Childhood	23
Incidence of adverse events prompting switching between biologics among adults with asthma: A retrospective cohort study	23
Global burden of vaccine‐associated angioedema and their related vaccines, 1967–2023: Findings from the global pharmacovigilance database	23
Identification of a functional DOCK8 gene polymorphism associated with atopic dermatitis	23
Helminths' therapeutic potential to treat intestinal barrier dysfunction	23
Physical exercise, immune response, and susceptibility to infections—current knowledge and growing research areas	23
Eosinophilic allergic rhinitis is strongly associated with the CD45RBlo subset of CD161+ Th2 cells that secretes IL‐2, IL‐3, IL	23
Effect of anti‐IL‐5 biologics on weight and body mass index	23
Corrigendum to “Immune Regulation by Intralymphatic Immunotherapy With Modular Allergen Translocation MAT Vaccine”	23
Patient‐centered dupilumab dosing regimen leads to successful dose reduction in persistently controlled atopic dermatitis	22
Downregulation of Tight Junction Protein MAGI1 by Interferon‐γ Contributes to Barrier Dysfunction in Chronic Rhinosinusitis With Nasal Polyps	22
Exhaled Nitric Oxide and Sputum Eosinophils Are Complementary Tools for Diagnosing Occupational Asthma	22
Direct oral penicillin challenge for penicillin allergy delabeling as a health services intervention: A multicenter cohort study	22
Allergen‐Specific IgE is a Stronger Predictor of Remission Following Peanut Oral Immunotherapy Than Age in Children Aged 1–10 Years	22
Bulk T‐cell receptor sequencing confirms clonality in pediatric eosinophilic esophagitis and identifies a food‐specific repertoire	22
Allergenic potency of various foods of mammalian origin in patients with α‐Gal syndrome	22
Eczema herpeticum in atopic dermatitis	22
Metabolomics analysis of metabolic patterns in chronic rhinosinusitis with nasal polyps	22
The association between allergic rhinitis and the risk of coronavirus disease 2019 (COVID‐19): A national survey in China	22
Long‐term changes in milk component immunoglobulins reflect milk oral immunotherapy outcomes in Finnish children	22
Allergen immunotherapy for asthma prevention: A systematic review and meta‐analysis of randomized and non‐randomized controlled studies	22
Systematic review of the association between short‐chain fatty acids and allergic diseases	22
	21
A single dose of BNT162b2 vaccine elicits strong humoral response in SARS‐CoV‐2 seropositive individuals	21
Migration and allergic diseases: Findings from a population‐based study in adults in Amsterdam, the Netherlands	21
Selective eosinophil necroptosis contributes to airway inflammation and remodeling in asthma	21
Identification of a defensin as novel allergen in celery root: Api g 7 as a missing link in the diagnosis of celery allergy?	21
Issue Information	21
Immune‐epithelial barrier interactions mediate intestinal adaptation to diverse diets	21
Induction of immunosuppressive CD39 but not the trafficking C‐C chemokine receptor 4 on Treg during LAR in mite allergic asthma	21
Spatial transcriptomics combined with single‐cell RNA‐sequencing unravels the complex inflammatory cell network in atopic dermatitis	21
Corrigendum: Role of yes‐associated protein in interleukin‐13 induced nasal remodeling of chronic rhinosinusitis with nasal polyps	21
Molecular reactivity profiling upon immunotherapy with a 300 IR sublingual house dust mite tablet reveals marked humoral changes towards major allergens	21
Issue Information	21
TH2 cytokines and Staphylococcus aureus cooperatively induce atopic dermatitis‐like transcriptomes	21
Safety of combining biologics in severe asthma: Asthma‐related and unrelated combinations	20
CMTM4 as a new partner for IL‐17 receptor: Adding a piece in the puzzle of IL17‐driven diseases	20
	20
Issue Information ‐ TOC	20
Updates in biologic therapy for chronic rhinosinusitis with nasal polyps and NSAID‐exacerbated respiratory disease	20
Anaphylaxis and desensitization differently activate and induce IL‐8 release by mast cells in a human peanut allergy in vitro model	20